Strategy

Self-leadership in Developing Mental Capital

An essential approach for effective multicultural and multidimensional leadership

Leading in todays culturally diverse workplaces with multidimensional processes and stakeholders requires individuals to adapt to new environments learn new skills and manage a range of stresses and strains between the interface of professional and personal life

DRUG REGULATIONS AND PHARMA COMPANIES’ PLAN OF COMPLIANCE

The Pharmaceutical industry has been growing in parallel to human evolution

Promoting Regulatory Collaboration and Convergence in Asia

In the WHO published an article in its Drug Information Bulletin titled Collaboration not competition developing new reliance models The articles authors argued that modern medicines manufacture and distribution were becoming more and more globalized and that as a consequence the manufacturing processes and supply chains of pharmaceutical products...

COACHING BRAND STRATEGY

IMPORTANT BUT DIFFICULT

When researching my latest book life sciences CEOs told me that the most important and fulfilling part of their job was developing the people who worked for them

IS THE INDIAN PHARMA INDUSTRY AS BLACK AS IT IS PAINTED?

Let me put up the disclaimers up front I have been an employee in the Indian pharma industry and currently run a consultancy business where several leading pharma companies are our clients

Reshaping Pharmacovigilance

ISOP ISRAEL experiencecan

Pharmacovigilance has undergone tremendous changes since the Vioxx story in which triggered the risk management approach worldwide

DRUG PRICING FOR PERSONALISED MEDICINE

IS INDICATION-BASED PRICE THE SOLUTION?

Personalised medicine is going to change the shape of the pharmaceutical market in the years to come

REGULATORY ASPECTS OF GENOTOXIC IMPURITIES

As per ICH QA guidelines impurity in a drug substance is any component of the drug substance that is not the chemical entity defined as the drug substance and as per ICH QB guidelines impurity in any component of the drug product that is not the chemical entity defined as the drug substance or an excipient in the drug product

Designing Sustainable High Performance in Business-to-Business Collaborations

With a cognitive systems engineering approach

In todays fast paced world of biopharmaceutical innovation no one individual or single organisation can really work alone

Today’s Line Managers

More of mentors and facilitators and much less of bosses

Gone are the days when line managers used to visit once in a while for joint working with their team members for a few days meet some important doctors and before leaving issue stern instructions to the team members that they should meet their targets without fail failing which they may not be in the team for long